Okihisa Tokuda

Title: Okihisa Tokuda: Innovator in Medicinal Chemistry

Introduction

Okihisa Tokuda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that can aid in the treatment of hyperglycemia-related diseases.

Latest Patents

Tokuda holds a patent for a spiroindoline compound, which is represented by a general formula. This novel compound exhibits glucokinase-activating action in the liver and pancreatic β-cells. It is particularly useful as an agent for preventing and treating diseases caused by hyperglycemia, such as diabetes. The patent details various structural components of the compound, including nitrogen-containing heteroaryl groups and various substituents.

Career Highlights

Tokuda is associated with Kowa Company Limited, where he has been instrumental in advancing research and development in medicinal agents. His work has led to innovative solutions in the pharmaceutical industry, particularly in diabetes management.

Collaborations

He has collaborated with notable colleagues, including Shin Tanikawa and Shinsuke Itoh, to further enhance the research and development efforts at Kowa Company Limited.

Conclusion

Okihisa Tokuda's contributions to medicinal chemistry, particularly through his patented spiroindoline compound, highlight his role as an innovator in the field. His work continues to impact the treatment of diabetes and related conditions.